Status:
UNKNOWN
Impact of Early and Severe Fetal Growth Restriction on Neurodevelopmental Outcomes in Preterm Infants
Lead Sponsor:
Central Hospital, Nancy, France
Conditions:
Severe Intra-uterine Growth Restriction
Preterm Birth
Eligibility:
All Genders
Up to 2 years
Brief Summary
Very early onset intra uterine growth restriction (IUGR) affects 5-10% of pregnancies and is the second leading cause of perinatal mortality. However, there is few studies on this subject, especially...
Detailed Description
Method: A monocentric retrospective case control study will be conducted at the Nancy University Hospital. Each infant included (cases) will be match to 2 controls based on gestational age, period an...
Eligibility Criteria
Inclusion
- Infants born before 34 weeks of gestational age, and whose antenatal files were discussed at the pluridisciplinary antenatal diagnosis center of Nancy from 2010 to 2020 with diagnosis of IUGR confirmed between 22 and 25 years of age. IUGR is defined by estimated fetal weight inferior to the 3rd percentile for the gestational age (Audipog curves).
- Each infant included will be matched to 2 controls on gestational age, period and sex
Exclusion
- no
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05381272
Start Date
January 1 2010
End Date
December 31 2022
Last Update
May 19 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.